Lv21
110 积分 2023-05-27 加入
Response to Ipilimumab and Nivolumab in a Patient With Malignant Peritoneal Mesothelioma
2小时前
已完结
Clinical outcome and prognostic factors for immunotherapy-based treatments in patients with platinum-refractory germ cell tumor
3个月前
已完结
Cytoreductive Surgery Plus HIPEC With and Without NIPEC for Malignant Peritoneal Mesothelioma: A Propensity-Matched Analysis
4个月前
已完结
Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative
5个月前
已完结
[Primary peritoneal epithelioid mesothelioma with a STK11 gene mutation: report of a case]
6个月前
已完结
Venous Thromboembolism in Peritoneal Mesothelioma: Uncovering the Hidden Risk
6个月前
已完结
2022 PSOGI Consensus on HIPEC Regimens for Peritoneal Malignancies: Diffuse Malignant Peritoneal Mesothelioma
6个月前
已完结
Natural History and Management of Small-Bowel Obstruction in Patients After Cytoreductive Surgery and Intraperitoneal Chemotherapy
7个月前
已完结
Predictors of Small Bowel Obstruction Post-Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
7个月前
已完结
Venous Thromboembolism in Peritoneal Mesothelioma: Uncovering the Hidden Risk
8个月前
已完结
皖公网安备34019202002308
